Year 2 Compliance Standard:
Clinical pathway compliance required for year 1 pathways: breast, colon, lung cancer (80%) and supportive care (80%)
Clinical pathway compliance required for year 2 pathways: lymphoma, myeloma, ovarian, prostate, renal cancer (70%), and supportive care (80%)
Qtr. 1-3 Compliance Update:
Individual compliance information can be accessed through the Pathways web portal.
Proportion of Participating Practices Achieving Compliance Thresholds for Both Treatment and Supportive Care Pathways:
Proportion of Sites Meeting 70% Compliance Threshold by Tumor Type:
|
FOR PATHWAYS PROGRAM INQUIRIES CONTACT: | |
Jane M. Tozer
Manager of Business Operations & Clinical Pathways
|